LYTIX BIOPHARMA ASLYTIX BIOPHARMA ASLYTIX BIOPHARMA AS

LYTIX BIOPHARMA AS

No trades
See on Supercharts

LYTIX fundamentals

LYTIX BIOPHARMA AS revenue breakdown overview

LYTIX BIOPHARMA AS revenue for the last year amounted to 10.96 M NOK, the most of which — 11.13 M NOK — came from its highest performing source at the moment, Oncolytic Peptides, the year earlier bringing 3.99 M NOK. The greatest contribution to the revenue figure was made by United States — last year it brought LYTIX BIOPHARMA AS 11.13 M NOK, and the year before that — 3.99 M NOK.

By source
By country